201 related articles for article (PubMed ID: 26122096)
1. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.
Thomas M; Bayha C; Klein K; Müller S; Weiss TS; Schwab M; Zanger UM
BMC Cancer; 2015 Jun; 15():488. PubMed ID: 26122096
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.
Shah YM; Morimura K; Yang Q; Tanabe T; Takagi M; Gonzalez FJ
Mol Cell Biol; 2007 Jun; 27(12):4238-47. PubMed ID: 17438130
[TBL] [Abstract][Full Text] [Related]
3. E
Chang-Lee SN; Hsu HH; Shibu MA; Ho TJ; Tsai CH; Chen MC; Tu CC; Viswanadha VP; Kuo WW; Huang CY
Pathol Oncol Res; 2017 Jul; 23(3):477-485. PubMed ID: 27757837
[TBL] [Abstract][Full Text] [Related]
4. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
[TBL] [Abstract][Full Text] [Related]
5. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
[TBL] [Abstract][Full Text] [Related]
6. Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells.
Thomas M; Bayha C; Vetter S; Hofmann U; Schwarz M; Zanger UM; Braeuning A
Mol Pharmacol; 2015 Jun; 87(6):1013-20. PubMed ID: 25824487
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
8. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
Gonzalez FJ; Shah YM
Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
[TBL] [Abstract][Full Text] [Related]
10. Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron.
Wen G; Ringseis R; Eder K
Biochem Pharmacol; 2010 Mar; 79(5):768-76. PubMed ID: 19819229
[TBL] [Abstract][Full Text] [Related]
11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
Szalowska E; Tesfay HA; van Hijum SA; Kersten S
BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
[TBL] [Abstract][Full Text] [Related]
13. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
[TBL] [Abstract][Full Text] [Related]
14. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
Morimura K; Cheung C; Ward JM; Reddy JK; Gonzalez FJ
Carcinogenesis; 2006 May; 27(5):1074-80. PubMed ID: 16377806
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor α (PPARα) mRNA expression in human hepatocellular carcinoma tissue and non-cancerous liver tissue.
Kurokawa T; Shimomura Y; Bajotto G; Kotake K; Arikawa T; Ito N; Yasuda A; Nagata H; Nonami T; Masuko K
World J Surg Oncol; 2011 Dec; 9():167. PubMed ID: 22168458
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARalpha activation and oxidative stress.
Zhang X; Li L; Prabhakaran K; Zhang L; Leavesley HB; Borowitz JL; Isom GE
Toxicol Appl Pharmacol; 2007 Aug; 223(1):10-9. PubMed ID: 17573087
[TBL] [Abstract][Full Text] [Related]
18. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC
Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543
[TBL] [Abstract][Full Text] [Related]
19. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
